Focus: Childhood Cancer Predisposition
Consortium: Consortium for Childhood Cancer Predisposition (C3P)
Headquarters: Emory University
Consortium Manager: Chloë Edgerton,

C3P LogoThe long-term goal of this consortium is to improve outcomes for children at high risk for cancer due to hereditary tumor predisposition.  A major effort toward this goal is the establishment of a database and biorepository for pediatric cancer predisposition syndromes (CPS), including those with and without a cancer diagnosis, as a well as family members. Studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early tumor detection, and cancer prevention, which will ultimately improve care and outcomes for those with CPS.

The Consortium for Childhood Cancer Predisposition was formally established in 2020 as a collaboration of researchers from seven institutions that will contribute to the data commons.

Information for Researchers

Research Contact: If you are looking for a research project or if you have a research project that you are interested in conducting with C3P data, please contact study staff at

Data Contributors

Executive Committee

Garrett BrodeurChildren’s Hospital of Philadelphia
Lisa DillerDana-Farber Cancer Institute
Junne KamiharaDana-Farber Cancer Institute
Luke MaesePrimary Children’s Hospital, Salt Lake City
Suzanne MacFarlandChildren’s Hospital of Philadelphia
David MalkinHospital for Sick Children, Toronto
Kim NicholsSt. Jude Children’s Research Hospital
Melissa PerrinoSt. Jude Children’s Research Hospital
Sharon PlonTexas Children’s Hospital
Christopher PorterChildren’s Healthcare of Atlanta
Surya RednamTexas Children’s Hospital
Joshua SchiffmanPrimary Children’s Hospital, Salt Lake City
Anita VillaniHospital For Sick Children, Toronto

Bolded names indicate Executive Committee co-chairs.